电前庭刺激 (VeNS) 对失眠的成年人有效性:双盲,随机化,假控制试验
Teris Cheung1,2, Joyce Yuen Ting Lam1,2, Kwan Hin Fong1
1School of Nursing, The Hong Kong Polytechnic University, Hong Kong SAR, China.
Dialogues in clinical neuroscience
|July 12, 2025
概括
电气前庭刺激 (VeNS) 显著降低了失眠的严重程度,并改善了香港成年人的生活质量. 这种非药物治疗对初级失眠管理有希望.
科学领域:
- 神经调节是一种神经调节.
- 睡眠医学 睡眠医学
- 临床试验 临床试验
背景情况:
- 失眠是一种影响全球人口的普遍睡眠障碍.
- 对于失眠的非药物干预措施有需求.
- 这项研究解决了亚洲关于失眠治疗的研究缺口.
研究的目的:
- 评估电前庭刺激 (VeNS) 对香港成年人治疗失眠的疗效.
- 评估VeNS对睡眠和生活质量影响的可持续性.
主要方法:
- 一个双盲的,随机的,假的受控试验.
- 101名患有失眠症状的成年人在四周内接受了20次活跃或假的VeNS治疗.
- 评估包括失眠严重程度,睡眠质量和生活质量在基线,干预后,以及1个月和3个月的随访.
主要成果:
- VeNS组在干预后和三个月的随访期间显示不眠症严重程度显著降低 (p < 0.05).
- 在干预后的VeNS组中观察到生活质量 (角色-身体) 的改善.
- 没有报告任何重大不良事件,表明安全性.
结论:
- 电气前庭刺激 (VeNS) 是一种安全且潜在有效的非侵入性神经调节装置,用于治疗初级失眠.
- VeNS可以作为失眠的辅助治疗.
- 需要进一步的多站点研究来证实VeNS的疗效.
相关概念视频
Management of Insomnia
324
The sleep cycle, an integral part of human health, consists of several stages with distinct characteristics and functions. It begins with a transition from wakefulness to sleep, known as the light sleep phase, followed by the restorative deep sleep phase, essential for physical recovery and growth. The cycle concludes with the Rapid Eye Movement (REM) phase, characterized by high brain activity and vivid dreaming. Insomnia, a prevalent sleep disorder, involves difficulty falling asleep, staying...
324
Electroconvulsive Therapy
200
Electroconvulsive therapy (ECT), or shock therapy, remains a critical biomedical intervention for severe, treatment-resistant depression. While its origins can be traced back to Hippocrates' observations that malaria-induced convulsions alleviated mental illness, modern ECT has evolved significantly from its earlier, more primitive applications. First introduced in 1938 by Ugo Cerletti and his colleagues, ECT involves inducing controlled seizures using electrical currents. In its early...
200
Sedatives and Hypnotics Drugs: Miscellaneous Agents
245
Sedatives and hypnotics encompass a wide range of substances, each with its unique mechanism of action, uses, and potential adverse effects.
Melatonin congeners like ramelteon (Rozerem) and tasimelteon (Hetlioz) selectively bind to melatonin receptors (MT1 and MT2) and thus mimic the actions of melatonin, a hormone that regulates sleep-wake cycles. Tasimelteon is primarily used for non-24-hour sleep-wake disorder, common in blind patients. They are also used to treat conditions like insomnia...
Melatonin congeners like ramelteon (Rozerem) and tasimelteon (Hetlioz) selectively bind to melatonin receptors (MT1 and MT2) and thus mimic the actions of melatonin, a hormone that regulates sleep-wake cycles. Tasimelteon is primarily used for non-24-hour sleep-wake disorder, common in blind patients. They are also used to treat conditions like insomnia...
245


